Get the Stockscreener App
53.20
3.20%
-1.55
Bright Minds Biosciences Inc stock is traded at $53.20, with a volume of 66,713.
It is down -3.20% in the last 24 hours and down -0.49% over the past month.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
See More
Previous Close:
$54.75
Open:
$55.09
24h Volume:
66,713
Relative Volume:
0.67
Market Cap:
$375.13M
Revenue:
-
Net Income/Loss:
$-4.98M
P/E Ratio:
-40.37
EPS:
-1.3177
Net Cash Flow:
$-3.85M
1W Performance:
-9.83%
1M Performance:
-0.49%
6M Performance:
+64.75%
1Y Performance:
+10.00%
1-Day Range:
$51.03
$56.00
1-Week Range:
$51.03
$59.05
52-Week Range:
$23.18
$70.23
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Name
Bright Minds Biosciences Inc
Sector
Industry
Phone
-
Address
-
Compare DRUG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRUG
Bright Minds Biosciences Inc
|
53.26 | 388.10M | 0 | -4.98M | -3.85M | -1.3177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.99 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.60 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.15 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.38 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.77 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | BTIG Research | Buy |
| May-13-25 | Initiated | TD Cowen | Buy |
| May-07-25 | Initiated | Chardan Capital Markets | Buy |
| Jan-23-25 | Initiated | Piper Sandler | Overweight |
| Jan-10-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-10-25 | Initiated | H.C. Wainwright | Buy |
| Nov-26-24 | Initiated | Robert W. Baird | Outperform |
View All
Bright Minds Biosciences Inc Stock (DRUG) Latest News
Is Bright Minds Biosciences Inc. a candidate for recovery playJuly 2025 Gainers & Real-Time Buy Zone Alerts - newser.com
Real time breakdown of Bright Minds Biosciences Inc. stock performanceQuarterly Trade Report & Technical Entry and Exit Tips - newser.com
What’s next for Bright Minds Biosciences Inc. stock priceMarket Sentiment Review & Verified Momentum Watchlists - newser.com
Published on: 2025-11-03 08:17:11 - newser.com
Using Python tools to backtest Bright Minds Biosciences Inc. strategies2025 Price Momentum & AI Enhanced Trading Alerts - newser.com
How to use a screener to detect Bright Minds Biosciences Inc. breakoutsJuly 2025 Selloffs & Verified Momentum Stock Ideas - newser.com
Published on: 2025-11-03 07:26:09 - newser.com
Using data models to predict Bright Minds Biosciences Inc. stock movementWall Street Watch & Verified Momentum Watchlists - newser.com
Is it time to cut losses on Bright Minds Biosciences Inc.2025 Key Lessons & Fast Exit and Entry Trade Guides - newser.com
Why Bright Minds Biosciences Inc. stock remains undervaluedJuly 2025 Sector Moves & Stock Portfolio Risk Management - newser.com
Building trade automation scripts for Bright Minds Biosciences Inc.July 2025 Gainers & Weekly High Return Forecasts - newser.com
Does Bright Minds Biosciences Inc. qualify in momentum factor screening2025 Sector Review & Daily Oversold Bounce Ideas - newser.com
Bright Minds Biosciences Inc. stock prediction for this week2025 Historical Comparison & AI Enhanced Trading Signals - newser.com
Can Bright Minds Biosciences Inc. rally from current levelsJuly 2025 Technicals & Fast Moving Stock Watchlists - newser.com
What machine learning models say about Bright Minds Biosciences Inc.Market Trend Report & Reliable Price Breakout Alerts - newser.com
Multi factor analysis applied to Bright Minds Biosciences Inc.July 2025 Gainers & Technical Entry and Exit Tips - newser.com
Will Bright Minds Biosciences Inc. stock attract ESG investors2025 Top Decliners & Technical Confirmation Trade Alerts - newser.com
Pattern recognition hints at Bright Minds Biosciences Inc. upsideMarket Performance Report & Weekly Stock Performance Updates - newser.com
Using fundamentals and technicals on Bright Minds Biosciences Inc.Market Volume Summary & AI Driven Stock Movement Reports - newser.com
Identifying reversal signals in Bright Minds Biosciences Inc.Trade Analysis Report & Momentum Based Trading Ideas - newser.com
A activityEarnings Performance Report & Weekly High Return Stock Opportunities - newser.com
Is Bright Minds Biosciences Inc. stock a safe investment in uncertain marketsJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
Is Bright Minds Biosciences Inc. stock a good choice for value investorsWeekly Stock Recap & Verified Entry Point Signals - newser.com
Bright Minds Biosciences Inc Stock Analysis and ForecastDividend Stock Watch & Get Trading Help From Experienced Users - earlytimes.in
Developing predictive dashboards with Bright Minds Biosciences Inc. dataPortfolio Value Report & Daily Technical Stock Forecast Reports - newser.com
Bright Minds Biosciences Inc Stock (DRUG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
1.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):